GX Acquisiton
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GX Acquisiton and buy or sell other stocks, ETFs, and their options commission-free!About GXGXU
Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other.
CEORobert Joseph Hariri Gordon, MD, PhD
CEORobert Joseph Hariri Gordon, MD, PhD
Employees123
Employees123
HeadquartersFlorham Park, New Jersey
HeadquartersFlorham Park, New Jersey
Founded2016
Founded2016
Employees123
Employees123
GXGXU Key Statistics
Market cap328.16M
Market cap328.16M
Price-Earnings ratio-34.11
Price-Earnings ratio-34.11
Dividend yield—
Dividend yield—
Average volume2.18K
Average volume2.18K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$14.00
52 Week high$14.00
52 Week low$8.52
52 Week low$8.52
Stock Snapshot
With a market cap of 328.16M, GX Acquisiton(GXGXU) trades at $11.63. The stock has a price-to-earnings ratio of -34.11.
On 2025-12-15, GX Acquisiton(GXGXU) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for GX Acquisiton(GXGXU) stock has reached 0, versus its average volume of 2.18K.
Over the past 52 weeks, GX Acquisiton(GXGXU) stock has traded between a high of $14.00 and a low of $8.52.
Over the past 52 weeks, GX Acquisiton(GXGXU) stock has traded between a high of $14.00 and a low of $8.52.